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1. Introduction  
Oral cancer (OC) is considered a serious public health problem that causes great 
morbidity and mortality in the population. While OC has a lower incidence than other 
malignant tumors, it is known to produce high mortality and serious disturbances or 
discomfort in the patient as a consequence of either the tumor itself or of the treatment. 
The Oral Squamous Cell Carcinoma is the most common malignant tumor of the lip, oral 
cavity and oropharynx (90% of the cases) while the remaining 10% of the cases are mainly 
melanomas, sarcomas, minor salivary gland carcinomas and metastatic cancers (Scully et 
al., 2006).  
In this chapter the attention is focused on the clinical characteristics of OSCCs.  
Topics: Clinical presentation, Symptoms, Diagnosis, Prognosis, Oral and Dental Management 
and Psychological aspects of patient care.  
2. Clinical presentation. Symptoms 
Oral Squamous Cell Carcinoma (OSCC) presents different clinical aspects which are related 
with the location of the tumor, evolution time, precancerous lesions and risk factors. The 
most frequent clinical aspects are: tumor, ulcer, vegetans, verrucous and mixed forms such 
as ulcerous-vegetans or verrucose- ulcers (Boring et al., 1994). 
The diagnosis of early lesions such as in-situ or microinvasive carcinoma, represents a real 
challenge for health professionals. Leukoplakia, erythroplakia or erythroleukoplakia are the 
most frequent clinical aspects, which may present superficially eroded areas. Chorion 
infiltration  may be suspected when increased consistency on palpation is observed. The 
abovementioned lesions are asymptomatic, tend to keep their size, may show changes in the 
surface and do not respond to local treatments. The lesion can progress and develop as an 
exophytic, irregular lobulated lesion or adopt an endophytic growth pattern characterized 
by a depressed ulcer with grayish-white edges, elevated, everted and indurate borders and 
an infiltrated base. In most cases, lesions are asymptomatic; pain appears only when 
muscles or nerves are invaded at advanced stages of the disease. (Neville et al., 2002; 
Silverman et al., 1998) 
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According to different authors, the lip is the most common location of OSCCs. In such cases, 
patients are likely to consult a physician or a dermatologist while in cases of tongue tumors, 
consultation to the dentist is more frequent. The paramedial area of the inferior lip is the 
most often region affected by lip cancer whereas the most prevalent precancerous lesions 
are actinic chronic cheilitis. OSCCs most common clinic manifestations are the loss of 
superficial tissue, erosion, ulcers (Fig.1) and occasionally exophytic shaped lesions: 
keratotic, verrucous or vegetant, with tumorous or “skin horn” aspect (Neville et al., 2002; 
Silverman et al., 1998). Chronic exposure to the sun produces in affected patients an 
alteration of the shape of the lip called lip everted or "lip on balcony”. 
A significant atrophy of the vermillion area with scales that do not tend to shed and 
therefore accumulate to form keratosis can often be observed. This type of lesions alternate 
with white lesions and erythro-leukoplakia areas that are prone to cracking, erosion or 
ulceration which are called actinic cheilitis. Lip cancer develops slowly and in advanced 
stages it can extend to the corner of the mouth or to the gingiva. It can also develop 
metastatic lymph nodes in submental and submandibular areas (Grinspan, 1983). 
 
Fig. 1. In-situ carcinoma of the lower lip vermillion 
Tongue carcinoma is the most commonly observed OC into the oral cavity; traumatic 
lesions, leukoplakia and lichen planus are predominant precancerous conditions. Tongue 
carcinoma represents 30-40% of OCs, the lateral tongue being the most frequent situation 
(80%), followed by ventral and dorsum (Brandizzi et al., 2008). 
Lateral border of the tongue and ventral surface OCs are usually preceded by traumatic 
lesions caused by sharp cusps or sharp edged teeth, by badly positioned teeth or by 
maladjusted dentures that chronically rub the mentioned areas. Ulcerated forms are the 
most frequently observed, see Fig 2, followed by exophitic tumor, which generally produce 
pain irradiating to the ear. In the ventral area, ulcer-vegetant or mixed forms predominate. 
Tumors on the dorsum are generally associated to lichen planus or to leukoplakia lesions. 
They are clinically observable as ulcerated forms tend to expand on the surface rather than 
go deeper into it. The lateral border of the tongue and the floor of the mouth (with 
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extensions to the back lateral soft palate and tonsillar areas) combine to form a horse shoe-
shaped region in the oral mucosa that was described by Jovanovic et al., (1993) as highly 
risky  for cancer development and also as a bad prognostic area.  
These tumors tend to evolve towards the ventral side and to the floor of the mouth.  In the 
first consultation, 40% of the patients have lymph nodes. When the lesion has more than 4 
cm, lymph nodes are present in  90% of the cases (Grinspan et al., 1983). Tumors located in 
the anterior half of the tongue usually lead to lymphadenopathy in the suprahyoid region 
while those located in the posterior half lead to submaxillary, carotid and lateropharyngeal 
nodes. Contralateral nodes are more frequent from tumors in the ventral surface and floor of 
the mouth (Shah et al., 1990; Grinspan, 1983).  
 
Fig. 2. Tongue infiltrant SCC, T2 N1 Mo  
According to our experience in Argentina, OSCCs in gum and alveolar ridge are the 2nd 
most frequent locations (Brandizzi et al., 2008.) which is not the case in other countries 
(Boudewijn  et al., 2009,  Chandu et al., 2005). It is difficult to detect previous lesions when 
the carcinoma is located in the gingival or alveolar ridge. In such locations, however, it is 
common to associate them with periodontal disease.  
Chronic inflammatory processes would release genotoxic mediators that would stimulate 
the accumulation of genetic defects leading to the appearance of malignant cells. In its initial 
stage, gingival carcinoma looks like a red or/and white spot slightly vegetant, extending on 
the surface due to the resistance offered by the periosteum (Fig 3). As OSCC advances, it 
adopts a tumoral shape, it may invade the bones, produce loosening of teeth and cause pain 
or trismus. Its progress through the lymph affects the submental, submandibular and 
carotid regions, these ones becoming the most common bilateral metastases. The antero 
inferior lesions progress towards the floor of the mouth and to the ventral side of the 
tongue. If the tumor is located in the posterior zone, it invades the floor of the mouth as well 
as the masticatory muscles. 
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Fig. 3. Gum carcinoma, the tooth was lost due to bone tumor invasion 
The floor of the mouth OSCC starts mainly in the anterior area as red and/or white spots, 
plaque or nodular, ulcerated lesions, later indurated at palpation (Fig. 4). It is not painful at 
an early stage although the tongue´s mobility can eventually be impaired. It advances from 
the surface to the depths of the tissues, invading the floor of the mouth muscles, the 
submental, submaxillary and cervical nodes.  
 
Fig. 4. Floor of the mouth, infiltrant SCC, two foci born in a leukoplakia   
Most buccal mucosa SCC is characterized by developing on previous lesions. The 
leukoplasiform and erythroplastic forms are commonly observed in the anterior part of the 
buccal mucosa while in the posterior one it is more often secondary to traumatic lesions or 
lichen planus. One of the first signs of the transformation is the induration of erythoplastic 
lesions that tend to develop an exophytic aspect as they grow (Fig. 5). This type of SCC rarely 
presents ulcers whereas differentiated histopathologic forms are predominant. When SCC 
appears in the posterior third of the buccal mucosa, it usually presents itself as endophytic or 
ulcers; undifferentiated histological types is the most frequent that have a worse prognosis 
than in the anterior third. The affected nodes are generally situated in the submaxillary area 
and less frequently in the cervical or facial ones (Grinspan, 1983; Jovanovic et al., 1993).  
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Fig. 5. OSCC of the buccal mucosa, an exophytic aspect. 
When we analized the habits associated to OSCC location, we observed that 85%-90% of the 
patients affected with floor of the mouth and oropharygeal carcinoma were smokers and 
drinkers. Fewer than 40% of those with gum and tongue carcinoma had both habits (Fig. 6). 
 
 
Fig. 6. Risk factors and location of the tumor 
To highlight: It is essential for everyone to undergo a proper oral examination. Pain in itself 
is not a reliable indicator of malignancy; in many of the studied cases, early lesions were 
associated with only minor discomfort.  
2.1 Lymph nodes 
According to the natural history of OSCCs, invasive lesions would lead to their spreading 
through the lymph nodes. Mobile, painless nodes whose volumes increase in course of time, 
and fix to surrounding tissue in the advanced stages, are those clinically suggestive of 
malignancy.   
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Union for International Cancer Control (UICC) recommended to classify the location of 
lymph nodes in the following levels: 
Level I: submandibular and submaxillary nodes. 
Level II: upper jugular nodes. 
Level III: jugular media. 
Level IV: lower jugular. 
Level V: nodes in the posterior triangle, bounded at the back by the anterior border of the 
trapezius muscle, anteriorly by the posterior border of the sternocleidomastoid and below 
by the clavicle. Descriptive purposes can be divided into high, medium and low by two 
horizontal planes: the superior plane is situated below the hyoid bone and the inferior one 
in the lower edge of the cricoid cartilage. 
Level VI: lymph nodes in the central compartment, which extends from the suprasternal 
notch to the hyoid bone. Lateral boundaries are formed on each side by the body´s internal 
carotid sheath. 
Level VII: lymph nodes located in the upper mediastinum, below the suprasternal notch. 
2.2 TNM system and staging 
According to the literature, the first classification of malignant tumors is Pierre Denoix´s 
(1944) Tumor Node Metastasis (TNM), based on the extent of primary tumor (T), 
involvement of regional lymph nodes (N) and metastasis at distance (M). Such classification 
also applies to OSCCs of the mouth. Proper classification and staging allows the physician 
to determine treatment more appropriately, evaluate results of management more reliably 
and compare worldwide statistics reported from various institutions. 
Currently, the American Joint Committee on Cancer (AJCC) and the UICC periodically 
update cancer staging, which is used by physicians and health care professionals 
throughout the world to facilitate the uniform description of neoplastic diseases. UICC rules 
to classify tumors are: 
- The classification applies only to carcinomas in the lip vermilion, in the oral cavity, 
pharynx, larynx, sinuses mucous including minor salivary gland tumors. 
- There should be histological confirmation. When the histology comes from another 
institution, it is recommended to have it reviewed by the pathologist in the working 
team.  
- The extent of the disease should be evaluated by clinical examination, endoscopy and 
imaging.  
In patients with advanced OSCC plus a history of heavy smoking, chest Computer 
Tomography (CT) is recommended before deciding on treatment because of the 
considerable possibility of undetected metastases in previous X-Ray tests.  
The staging of each case must be determined before treatment and should not be changed 
whatever findings emerge after starting it. You can add such findings but you cannot 
change the staging. If doubts arise concerning it, assigning the patient the lowest category is 
the most convenient procedure. 
Tables 1 shows the TNM classification and Table 2 describes the staging.  
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T N M 
Tumor Nodule Metastasis 
Tis: in situ Carcinoma 
N0: nonpalpable regional 
lymph node 
M0: No distant 
metastasis 
T1: < 2 cm. diameter 
N1: ipsilateral single ≤3 cm 
palpable nodes 
M1: clinical or 
radiographic evidence 
of metastasis 
T2: 2 to 4 cm. diameter 
N2: ipsilateral or contralateral 
palpable lymph nodes  
3 to 6 cm. subdivided into: 
N2a: an ipsilateral single node 
3 to 6 cm. 
N2b: ipsilateral multiple  
≤6 cm. 
N2c: contralateral or  
bilateral  ≤6 cm. 
 
T3: Tumor  >4 cm. diameter N3:  >6 cm.  
T4: invaded adjacent tissues 
T4a: moderately advanced local 
disease 
T4b: very advanced local disease 
  
Table 1. TNM Classification of malignant Tumors 
 
Stage  Tumor Node * Metastasis 
Stage 0 Tis N0 M0 
Stage I T1 N0 M0 
Stage II T2 N0 M0 
Stage III 
T1 
T2 
T3 
T3 
N1 
N1 
N0 
N1 
M0 
M0 
M0 
M0 
Stage IVA 
moderately advanced 
local/ regional 
disease 
T4a 
T4a 
T1 
T2 
T3 
T4a 
N0 
N1 
N2 
N2 
N2 
N2 
M0 
M0 
M0 
M0 
M0 
M0 
Stage IVB  
very advanced 
local/regional disease  
T4b Any N M0 
Stage IVC distant 
metastatic disease 
Any T 
Any T 
N3 
Any N 
M0 
M1 
* Extracapsular spread (ECS) of disease is added as ECS + or ECS—as a descriptor.  
These descriptors will not influence nodal staging. 
Table 2. Stage grouping for oral cavity, oropharyngeal, hypopharyngeal and laryngeal 
cancers from UICC: TNM Classification of Malignant Tumours 
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3. Variables that influence diagnosis 
3.1 Diagnostic delay  
Oral cancer is a global health problem of increasing incidence and mortality rates; more than 
500,000 patients worldwide are estimated to have oral cancer (Parkin et al., 2005). The 
International Association for Cancer Research (IARC) and the World Health Organization 
(WHO) latest records show an incidence of 263,020 cases (3.8 rate) with high mortality 
127,654 (1.9 rate ), (Ferlay et al., 2010).  
Unfortunately, the 5-year survival rate has not changed during the last half of the century, 
still being around 50–55% in spite  of the advances in diagnosis and treatment (Neville and 
Day, 2002). Early diagnosis is a foremost step for reducing cancer mortality (Boyle et al., 
2003), since the identification of smaller lesions allows less aggressive and debilitating 
treatments. However, almost half of intraoral cancers have late diagnosis (stages III or IV). 
Diagnostic delay is, therefore, the main reason why most patients´ OSCCs are discovered  in 
advanced stages when their diagnoses  are finally made. Late diagnosis is the result of either 
patient or professional delay (Kerdpon & Sriplung, 2001, Rogers et al., 2007). 
There is a vast literature  about the results of research on this interesting topic carried out  in 
populations from all over the world (Table 5).  
We investigated OSCC diagnosis delay in Córdoba in a retrospective study of  
clinical records of OSCC patients, examined in the Stomatology B service (a referral clinic 
for oral soft-tissue lesions) and in the Oncohematology Unit of Hospital Nacional  
de Clínicas (Morelatto et al., 2007). We included in that study patients diagnosed with 
OSCC  as their first cancer between 1992 and 2004. Oral exams and diagnosis at both 
centers were made by the same trained professionals and supervised by the same head 
professor. Age, sex and location of the OSCC, first signs or symptoms, and first 
consultation with a health professional (HP) were studied. Stage at the moment of the 
diagnosis was classified according to the 1997 version of the UICC, AJCC. The symptoms 
were classified as pain, swelling, ulceration, white lesions, poor denture fit and others. 
Stages III and IV (S III and S IV) were defined as advanced tumors and S I and S II as early 
ones (Brohua et al., 2005). 
In order to study the OSCC diagnostic delay, the authors described the following 
categories:  
A- Patient delay: considers the time elapsed between the first sign or symptom noticed by 
the patient and the first consultation with a HP. B- Professional delay: considers the period 
of time between the first consultation with a HP and the referral to  the specialist who 
performed the biopsy (Kerdpon & Sriplung, 2001). C- Patient and professional delay: 
considers the period of time between the final diagnosis and the beginning of treatment 
(Kowalski & Carvalho, 2001).   
A lapse of more than 30 days in any category (A, B or C) was regarded as delay (Shah & 
Lydiatt, 1995). The data aforementioned were statistically analyzed. 
In our study, 68% of the patients in the early stage and 54% in the advanced stage evidenced 
patient delay (see Table 3). On the other hand, 72% of the patients in the early stage and 61% 
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in the advanced stage had a professional delay of more than 30 days (Table 4). In both cases, 
the delay was more pronounced in early stages.  
 
Delay A 
<30 days 
n (%) 
30-60 days 
n (%) 
60-120 
days 
n (%) 
>120 days 
n (%) 
Total delay 
n (%) 
S I and II 6 (32) 2 (10) 3 (16) 8 (42) 13 (68) 
S III and IV 23 (46) 12 (24) 8 (16) 7 (14) 27 (54)* 
Total 29 (42) 14 (20) 11(16) 15(21) 40 (58) 
*In one patient, delay A was unknown.  
Table 3. Patient delay (A) related to the stage of the tumor. 
 
Delay B 
<30 days 
n (%) 
30-60 
days 
n (%) 
60-120 days 
n (%) 
>120 days 
n (%) 
Total delay 
n (%) 
S I y II* 5 (28) 4 (22) - 9 (50) 13 (72)* 
S III y IV 20 (39) 6 (12) 18 (35) 7 (14) 31 (61) 
Total 25 (36) 10 (14) 18 (26) 16 (23) 44 (64) 
* In one patient, delay B was unknown. 
Table 4. Professional delay (B) related to the stage of the tumor 
A similar finding was reported in Greece and in the Netherlands with 52% of patients with 
more than 3 weeks ( Pitiphat et al., 2002) and 46 days of delay, respectively ( Jovanovic et 
al.,1992). A median time of 3 months or more until diagnosis was described for Canada 
(Elwood & Gallagher, 1985), Italy (Mashberg et al., 1989), Finland (Soderholm, 1990),  
Denmark (Wildt et al., 1995) and Israel (Gorsky &Dayan, 1995). Although the results 
obtained in Argentina were more optimistic than in those of some other populations, the 
proportion of patients who had delayed diagnosis was still considerably high. The mean 
time between the first symptom and the consultation with a HP (delay A) was 2.5 months in 
females and 2.3 in males. The percentage of delay A of more than 1 month (68%) in Córdoba 
is similar to the value found by Jovanovic et al., 1992 (53.7%) and lower than results 
obtained by Pinholt et al., 1997, (92%). 
It should be considered that there are some limitations in the present research  namely, that 
many patients did not exactly recall the onset of their symptoms (Wildt et al., 1995). Pain 
was the most common first symptom, but more than half of the patients did not visit a 
medical facility to receive treatment before one month following that occurrence. Onizawa 
et al., 2003 consider that the symptom may not be bothersome or severe enough to seek 
professional help. 
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The time elapsed between the first symptom and its diagnosis was longer for women than 
for men in our population (77.5 and 67.8 days respectively); Wildt et al., 1995, reported 
similar results. In our research, we observed that 100% of lip cancers and 38% of tongue 
lesions were staged as early cancers at the time of diagnosis, while Gorsky & Dayan, 1995 in 
Israel found 82% in lip and 58% of tongue tumors in that stage. According to our research 
professional delay (B) was the most related variable  to the stage of the tumor at the time of 
diagnosis. As shown in Table 4, B was more important in early stages; this observation is 
relevant because treatment delay worsens the prognosis.  
 
Country Author / Year N Delay 
The Netherlands Jovanovic et al., 1992 50 patient 
Australia Dimitroulis et al., 1992 51 patient 
Brazil Kowalski et al.,1994 336 professional 
Israel Gorsky et al., 1995 543 professional 
Denmark Wildt et al., 1995 167 patient 
Malaysia Khoo et al., 1998 65 
Patient and 
professional 
Canada Allison et al., 1998 188 professional 
Thailand Kerdpon et al., 2001 161 
patient and 
professional 
Japan Onizawa et al., 2003 152 professional 
The Netherlands  Tromp et al., 2005 306 patient 
Ireland O´Sullivan et al., 2005 370 patient 
Netherlands Brouha et al., 2007 173 professional 
Table 5. Responsibility of diagnostic delay in oral cancer in different countries according to 
several authors 
OSCC diagnostic delay has been thoroughly studied and its causes seem to be always the 
same: (i)  unawareness of most of the population regarding the potential malignancy of oral 
lesions (patients’ delay), (ii)  inaccurate diagnosis on the part of the HP and (iii) delay in 
referral for treatment (Allison et al., 1998; Dimitroulis et al., 1992), see Table 5. 
Medical practitioners usually prescribe various medications; it is more common, however, 
that dentists adopt a more mechanical approach such as extracting teeth or adjusting 
dentures (Kerdpon & Sriplung, 2001). Both tend to be slow in suspecting malignancy.  
The findings of the present study also indicate that patients are partially responsible for 
delay in OSCC diagnosis.  
3.2 Awareness 
Due to the apparent lack of awareness of patients suffering from OSCC assisted by different 
services in various countries, we studied the general public in Cordoba City to assess levels 
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of awareness and knowledge of oral cancer, risk factors, suspicious clinical signs and 
parameters related to early consultation to HP (Robledo et al., 2008). Anonymous surveys 
were carried out, obtaining a systematic sampling from the 2004-2005 telephone directory of 
Cordoba City. Four hundred effective surveys were made to Argentine citizens older than 
18. Results: 41 % of the participants did not know of the existence of OC, the highest 
percentage of poor or no information was found among people younger than 30 years of 
age. Only 60% of those who knew about OC were able to name a risk factor, being tobacco 
the most easily associated. It is surprising that only 3% of the questioned people associated 
alcohol, related tobacco-alcohol consumption or unadjusted dentures as risk factors. Only 
45% had some knowledge about clinical manifestations, pain and ulcers being the most 
frequently mentioned. Though most of the surveyed population had consulted a dentist one 
or several times a year, only 32% could recall if they had had a comprehensive oral exam. 
Evidently, the population badly needs to be informed about risk factors and first clinical 
manifestations of OC and about the importance of early consultation.  
In a study of Humphris et al. (2004), a randomized controlled trial found that patients 
attending primary care who had read an information leaflet about head and neck cancer had 
increased awareness of risk compared to patients who had not seen the leaflet. A 
questionnaire of awareness of signs and symptoms and risks of oral cancer showed that all 
those who received the leaflet (smokers, non-smokers and past smokers) reported greater 
knowledge (p< 0.001). Smokers were 16 times more likely to perceive that they were at 
greater risk. 
It would also be highly necessary to have access to professionals with further training in the 
detection of precancerous lesions and OC early signs.  
4. Prognosis. Survival rate 
Cancers of the oral cavity have a high mortality rate and, despite the current progress in 
treatments, the situation has not improved. A five-year survival rate ranging from 30% to 
80% has been reported from several parts of the world. Survival rates are lower in 
developing countries (Sargeran et al. 2008). We made a research on that subject in Córdoba 
in an retrospective study of 89 clinical records of OSCC patients, followed in the 
Stomatology B Service and in the Oncology Unit of Hospital Nacional de Clínicas between 
1989-2005, (Bolesina et al., 2007). Survival rates were related to age, gender, location, stage, 
risk factors and treatment; 74% of the patients were male, age range was 23-93, median age 
60 years. The lowest survival rate was found between 61 and 70 years of age. After five 
years of OSCC diagnosis, the general survival rate reached 35—40 %. The most frequent 
cancer location was in the tongue (26%), followed by gum (23%) and floor of the mouth 
(11%). The highest mortality rate was due to tumors situated in the base of the tongue, gum 
and floor of the mouth, 100%, 88% and 85%, respectively. It was noted that 100% base of the 
tongue tumors , 90% gingiva and floor of the mouth tumors were discovered in advanced 
stages while 100% of lip tumors were diagnosed in early stages. 
The observed survival rate in OSCC stage I was 75% whereas only 23% patients survived in 
stage IV. When all the variables were analysed and related to survival rates, a value of p= 
0.001 was obtained for tumor stages (Fig. 7). 
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Fig. 7. Five year survival rates, according to OSCC stage at the moment of diagnosis 
When surgery was the only treatment indicated, patient survival rate was 55%. When 
radiotherapy complemented surgery, the rate decreased to 33%, which is in good agreement 
with the literature (Sargeran et al., 2008). 
As far as risk factors are concerned, it has to be pointed out that 49% of the patients were 
smokers and heavy drinkers; higher mortality rates were found specially in male patients 
having these habits compared to those with only one or none of them. The p value obtained 
for alcohol consumers and tobacco smokers was 0.04, see Fig 8.  
 
 
Fig. 8. Percentaje of patients who died before 5 years, related to risk factors 
In our study, we did not have a significant enough sample of young patients to reach 
definitive conclusions. However, previous studies show that younger people have a 
considerably better five-year survival. Age is therefore a determining factor to good 
outcomes for OSCC patients (Warnakulasurilya et al. 2007). Although it is well known that 
tobacco smoking and alcohol consumption are the strongest risk factors for the development 
of head and neck cancer, little information is available concerning both the prognostic value 
of these habits and that of quitting them after diagnosis.  
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Non-smokers with early stage OSCC have a better prognosis than former or current 
smokers at the same stage (Vora et al., 2003), which agrees with the results obtained in our 
study. 
Smoking cessation after diagnosis or starting OC therapy can improve survival rates. It is 
reported that head and neck cancer patients who admitted to continuing smoking during their 
radiotherapy treatment had a lower response and survival prospects than those who claimed 
to quit smoking prior to starting the treatment, with 2.5 RR (95% CI 1.4–4.4) (Browman et al., 
1993). RR of recurrence of the disease among smokers (non drinkers) was 2.9 compared to 
non/ex-smokers and 3.8 for those smoking >2 packets a day (Stevens et al., 1983). In a 
retrospective study in Southern England, RR for multiple primary cancers was higher in those 
patients who continued smoking and drinking after therapy (Warnakulasuriya et al., 2003).  
To sum up, these studies provide clear evidence that smoking cessation even after an oral 
cancer diagnosis improves prognostic outcomes. Oral cancer patients who were current 
drinkers showed higher mortality rates than former or non drinkers (Kowalski et al., 1994). 
Quitting drinking after diagnosis was also associated with improved survival outcomes, but 
the hazard ratios did not reach statistical significance.  
The findings suggest that rising alcohol consumption since the 1950s is more closely related 
to increasing intra-oral cancer incidence and mortality than smoking, a fact that is more 
evident among younger males since the early 1970s (Hindle et al., 2000). 
There are a myriad of risk factors that lead to OC, among them Human Papilloma Virus and 
other infections, chronic inflammations and social and environmental carcinogen conditions. 
These issues are the subject of continuous studies being carried on at present by several 
scientific teams. 
5. Patient management  
The decision about the adequate treatment for each patient should be made by an 
interdisciplinary committee of specialists in head and neck tumors. The choice of treatment 
largely depends on the site and stage of the disease and on the overall health status of the 
patient. Early stages of intraoral cancers are likely to be cured by surgery or radiation 
therapy. The election of the type of treatment is determined by the anticipated functional 
and cosmetic results and by the availability of the particular expertise required from the 
surgeon or radiation therapist for each patient. Advanced tumors (stages III and IV) are 
generally treated by surgery, followed by radiation therapy. 
The treatment for head and neck cancers, especially those involving the oral cavity, has 
changed in the last 10–20 years. It is now widely accepted that for advanced OC tumors, 
surgery combined with radiation therapy has a better outcome than if only one of those 
modalities is used. Although the impact of neo-adjuvant chemoradiation may increase 
survival, it may also increase morbidity considerably. 
It is worth mentioning that current advent of state-of-the-art technology applied to cancer 
treatments has significantly improved the quality of life of OC patients. However, there are 
only few data as to the length of survival in relation to new devices such as gamma rays, 
electrons, protons and atomic nuclei, tridimensional (3DR), stereotactic, Modulated Intensity 
Radiotherapy (MIR) and Image-Guided Radiation Therapy (IGRT). The new technology 
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allows the professional to better adjust radiation to the tumor, thus diminishing the damage 
inflicted to the surrounding healthy tissues, especially major salivary glands and 
maxillaries. Brachytheraphy is a still used resource; it requires the isolation of the radiated 
patient and it should be carried out by highly experienced professionals. 
In spite of all the above mentioned innovations, the occurrence of complications is high, 
which would inevitably delay the standard therapeutic protocols. This fact, in turn, would 
make patients prone to recurrence or to metastases.  
5.1 More frequent oral complications 
All treatments usually applied to deal with OSCC and also with head and neck cancers 
have a negative impact on  the patients, especially on their oral cavity; several complications 
can arise due to direct damage to oral tissues or to indirect regional or systemic toxicity. 
What is more, dental care is regarded by many patients as a low priority in their treatment. 
Surprisingly, 90% of the treated patients were found to have dental diseases such as caries, 
periodontal diseases or sepsis (Toljanic et al., 2002). The factors that influence intensity and 
duration of oral damage are: the medical and nutritional status of the patient, tobacco and 
alcohol use, oral hygiene and dental status, previous surgical interventions, and the 
indicated radiation treatment.  
5.1.1 Surgical risks and complications  
Surgical management of intraoral lesions typically includes both the primary lesion and  
cervical lymph nodes. Ideally, surgery is selected when permanent control of the tumor is 
sought. The tumour staging  is essential to determine whether only surgery  is indicated or 
whether radiation or chemotherapy may be needed later. 
The risks and sequels of surgery primarily depend on or develop from the extent of the 
tumor and its relationship to contiguous oral structures. Sequels may include disorders in 
speech and swallowing, pain, limitations in oral motor function; infections, enteral nutrition 
(e.g. tube feedings), facial, neck and shoulder malfunction, disturbances in mental health, 
fibrosis, cosmetic deficits and bone lesions. 
During resection of oral cancers, teeth and their supporting bone are often removed. In 
order to achieve functional rehabilitation, it is necessary to replace missing elements. Some 
patients may require an intraoral prosthesis for obturation of a velopharyngeal deficit or to 
reshape and augment the contours of a resected hard palate. The work of a speech therapist 
is crucial in this venture (Vendrell  & Ranking, 1999). 
5.1.2 Potential oral manifestations of radiation therapy  
Patients that receive radiation therapy in the oropharyngeal area for malignant tumors may 
undergo radiation therapy for 7 weeks with a dose going up to 7000cGy, depending on 
tumor type and location. Radiotherapy is associated with side effects that vary in intensity 
and duration and are dependent on several factors. Not all patients will experience all 
possible complications but they should be aware of the potential risks. 
Acute and chronic complications in the short and long term have been studied by different 
authors; some complications are described below. Hyposalivation during the 1st week of 
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radiation treatment amounts to 50-60% of the usual saliva flow. After a 7- week 
conventional treatment, it decreases to 20%. 
Hyposalivation subjective symptom xerostomy implies several other symptoms like 
dysphagia, dysgeusia, dysosmia and speach difficulties (Jansma et al., 1989). 
Xerostomy brings about a change in oral microflora and, as a result, cariogenic 
microorganisms streptococos mutans y lactobacilos  prevail in the saliva, causing caries and 
periodontal diseases. The oral mucosa becomes soft, irritable and susceptible of fungal 
infections (candidiasis) and inflammations (Daly & Drane,1972; Hinds,1971). 
Recently, preventive measures to decrease the effects of radiation induced xerostomy have 
been widely studied. To begin with, patients should give up  tobacco, alcohol and spicy, too 
hot, too cold or too hard foods and replace them by soft and moist nutrients. Secondly, they 
should be advised to be well hydratated and to use saliva substitutes. 
Salivary gland tissue does not recover from high doses of radiation. The quality and 
quantity of saliva is permanently changed. Taste loss and alterations may begin with the 
first 200-400 cGy. After three weeks of therapy, it takes 500-8,000 times normal 
concentrations of taste stimulant to elicit a normal taste response. Taste acuity levels usually 
return to normal within 2-12 months following completion of therapy, if adequate saliva is 
available (Jasma et al., 1989). Both mucositis and decreased salivary flow may contribute to 
taste alteration. 
Mucositis: Oral mucositis is the inflammation that takes place in the oral epithelium as a 
result of antineoplastic treatments such as radiotherapy, chemotherapy or bone marrow 
transplant  which are  very frequent in these treatments for oncohematologic disease. Not 
only do the consequences of the inflammation affect the quality of life of the patient but it 
can also mean a limitation in the application of the treatment, as well as an increase in 
hospital length of stay and therapeutic costs.  
Radiation-induced mucositis depends on the absorbed radiation dose, fractioning, delivery 
modality and soft tissue status. Other influential patient-related variables are age, sex, 
nutritional condition, oral microbiota, salivary flow and inflammation among others.  
The study of the degrees of severity of oral mucositis has yielded different results coming 
from diverse research centers. This constitutes a major obstacle for the study of mucositis. 
The lack of a uniform systematic approach adopted for its evaluation by means of oral 
examination makes it difficult to assess its consequences.  
The various existing scales to measure mucositis were analyzed by López Castaño et al., 
2005; Stone et al., 2007; Sonis et al., 1999; World Health Organization, 1979 (see Table 6). 
 
1 burning sensation and eritema 
2 
eritema, ulcers and possibility  
of solid food intake 
3 ulcers, liquid diet 
4  impossible feeding  
Table 6. Mucositis WHO Classification 
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Oral Infections: Health care providers should be concerned about preventing oral local and 
systemic infections in addition to managing their symptoms. Treating infections as soon as 
they are detected will help to reduce pain, as well as control the spread of infection. A 
fungal, bacterial or viral culture is recommended if infection is suspected. 
In patients undergoing head and neck radiotherapy, Candida colonization tends to increase 
during  the course of the treatment and remains increased if xerostomia occurs (Epstein et 
al., 1998; Ramirez-Amador et al., 1997). Candidiasis can cause a burning or scalding 
sensation, can distort taste and may interfere with swallowing. Its spread to the esophagus 
or systemic dissemination is a serious consequence (Rankin & Jones, 1999). Other 
opportunistic fungal infection is Histoplasmosis.  
Bacterial and viral infections are more common in neutropenic patients than in those 
affected by oral cancers. The detection and treatment of those infections represent a   
challenge to health professionals and should be the subject of a more extensive study. 
Nutritional deficiency: It is caused by the effects of mucositis, xerostomy, hypogeusia, and 
loss of appetite that can make eating an unpleasant painful chore, quite apart from the 
psychological implications that such discomforts may have on the eating function. 
Symptoms may include rapid weight loss, dehydration, nutritional stomatitis, and 
secondary oral infection, specifically candidiasis (Rankin & Jones, 1999). 
Caries: Even patients that have not suffered from dental caries for some time can develop 
them when  submitted to radiotherapy. Those caries differ considerably in clinical 
appearance, development, and progression from dental caries in non-irradiated patients. 
Radiation has a pernicious effect on the teeth since it makes them prone to decalcification. 
Post-radiation lesions develop in a distinct manner with initial sheer fracture of enamel 
followed by rapid decay of the exposed underlying dentin (Jansma et al.,1993; Jongebloed et 
al., 1988). Such lesions are mainly developed when the flow of saliva diminishes or when its 
properties are altered (Brown et al., 1975; Carl & Schaff, 1974). Furthermore, post- radiation 
lesions tend to occur at gingival margins, cusp tips, and incisal surfaces in contrast to typical 
caries, which develop in pits, fissures and proximal areas.  
There are three kinds of radiation- related carious lesions:  
First type: the lesion superficially covers the cervical tooth area, slowly progressing inwards 
until it often provokes the crown total destruction. This is less frequent in the molars, 
although the caries tend to appear on the surfaces of the whole molar area. 
The second type of lesion is a generalized superficial defect that first affects the buccal and 
later the lingual or palatal surfaces of the tooth crowns. The proximal surfaces are less 
affected.This lesion often begins as a diffuse, punctate defect and then progresses to 
generalized, irregular erosion of the tooth surfaces. In this type of lesion, decay localized at 
the incisal or occlusal edges is often observed. The result is a destruction of the coronal 
enamel and dentin, especially on the buccal and palatal surfaces. 
Third type: the lesion extends as a heavy brown-black discoloration over the whole set of 
tooth crown together with a marked wear of the oclusal and incisal sides (Vissink et al., 
2003).The areas just below the contact points seem to be the last areas to be affected by 
radiation caries. 
www.intechopen.com
 Oral Squamous Cell Carcinoma Clinical Aspects 
 
37 
Trismus and / or fibrosis: Spasms and/or fibrosis of the masticatory muscles and 
temporomandibular joint (TMJ) capsule, usually occurs 3-6 months after radiation therapy, 
with unpredictable frequency and severity. It is worsened by some surgical resections 
(Rankin & Jones, 1999). 
Limited opening may interfere with oral hygiene, dietary intake, use of prostheses and 
restricted access to dental care and general anesthesia (Barker et al., 1996).  
It is often observed that  floor of the mouth and neck  fibrosis bears a relation with 
individual predisposing factors, among which peripheric circulatory disorders can be 
mentioned. 
Soft tissue necrosis/osteoradionecrosis (ORN):  Soft tissue and bone necrosis may develop 
because tissues within the field of radiation become hypovascular, hypoxic and 
hypocellular. The threat of this sequel persists indefinitely, although the risk is minimal 
when the total dose of radiation is < 5000 cGy.  
The effects of radiation on bone, periosteum, connective tissue, and vascular epithelium 
generally develop over time and include suppressed osteoblastic activity, decreased cell 
numbers, disorganization of bone remodelling, hypovascularity and increased fibrosis. 
Smaller blood vessels are more sensitive than large vessels. Initially, there is a periarteritis 
and endarteritis that progress to fibrosis and loss of endothelium. This results in the 
narrowing and possible obliteration of the lumen, reducing the blood supply to all tissues 
within the radiation field. 
Factors that may contribute to an increased risk of necrosis include compromised 
vascularity from previous surgery, poor nutritional or health status, uncontrolled diabetes 
and heavy tobacco or alcohol use. Trauma may result from tooth extraction, invasive 
periodontal procedures and intraoral prosthetic appliances. The necrosis process may take 
place spontaneously or result from trauma, leading to non-healing soft tissue, bone 
lesions, and necrosis. The mandible is much more susceptible to ORN than the maxilla. 
The incidence of ORN is twice as high in dentate patients as it is among edentulous 
patients. 
Clinical manifestations of ORN may include pain, orofacial fistulas, exposed necrotic bone, 
pathologic fracture and suppuration (Barker et al., 1996).  
The management of patients with ORN depends on the severity of the necrosis  which may 
be controlled by local irrigation, antibiotic treatment, local sequestrectomy or wide 
segmental excision with or without reconstruction. Hyperbaric oxygen therapy is 
considered an adjunctive treatment for ORN, often used in conjunction with surgery, and 
has been associated with better success rates than surgery alone (Aitasalo et al.,  1995; 
McKenzie et al., 1993). 
5.2 Oral and dental management  
5.2.1 Pre oncologic treatment oral preparation 
With the increasing trend in outpatient management, including cancer therapies, every 
health care professional is a potential and integral part of the cancer treatment team that 
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once existed solely within the hospital environment. To provide optimal therapy, a 
functional, communicative, interactive team is critical to the successful management and 
outcome of the cancer patient. This includes the evaluation and treatment planning 
considering the overall patient health, tumor site, stage and tumor biologic status and 
patient´s cultural/socioeconomic status. Dentists, as part of a multidisciplinary team, have 
an active role before, during and after the treatment (Shaw, 1997). 
The aims of oral care programs for OC patients are: 
- to improve oral function and quality of life. 
- to improve and keep oral hygiene so as to reduce risk and severity of oral 
complications. 
- to eliminate oral infections and avoid tooth originated systemic ones. 
- to prevent, eliminate or control oropharyngeal pain. 
- to prevent or control salivary gland dysfunctions and tooth destruction. 
- to prevent or reduce the incidence of bone necrosis. 
The first step of the treatment should be a panoramic X-Ray in order to have a global vision. 
If tooth extractions are necessary for non-restorable or doubtful prognosis teeth (see criteria 
in Table 7), they should be made 15-20 days before radiation treatment and 5-10 days before 
chemotherapy.  
 
Caries (nonrestorable). 
Active periapical disease (symptomatic teeth). 
Moderate to severe periodontal disease (with mobility grade 2 and 3). 
Furcation lesions of grade II and III, periodontal pocket < 4 mm). 
Endo-periodontal processes. 
Lack of opposing teeth, compromised hygiene. 
Extensive periapical lesions (if not chronic or well localized). 
Partial impaction or incomplete eruption. 
Table 7. Criteria for pre-radiotherapy extractions 
Before starting radiotherapy, tissues must be healthy without tearing or leaks either in the 
oral mucosa or in the alveolar bones. Besides, endodontic treatment of deeply decayed teeth 
must be carried out, glass ionomer and resins must be used for cavity obturation, metallic 
reconstructions must be avoided, planing and polishing of the dental and prosthetic sharp 
cusps must be performed. There must be a tight control of microflora and of oral hygiene 
techniques. Fluoride tooth paste and adequate prothesis disinfection are highly advisable. 
5.2.2 During radiotherapy treatment 
A weekly check up by the interdisciplinary team will allow the professionals involved to 
detect early lesions and to make sure that the patient follows all preventive indications. 
www.intechopen.com
 Oral Squamous Cell Carcinoma Clinical Aspects 
 
39 
Good results were obtained when a preventive program including mechanical and chemical 
biofilm control was put into practice. 
5.2.3 After a radiotherapy treatment 
Very strict oral hygiene as well as frequent visits to the dentist are mandatory to prevent 
infections and caries formation since extractions are highly unadvisable due to impending 
ORN risk. 
It has become essential to implement specific training courses dealing with OC patient care, 
which should be progressively included in the grade curricula.  
6. Psychological aspects of patient care 
Oral cancer is a complex health problem that deeply affects the life of the patient since it 
involves vital body areas related to communication and emotions. Comparatively, it is even 
more disturbing than general cancer since head and neck cancer is clearly related to 
functional speech and swallowing problems; therefore, OC patients are among the most 
distressed sufferers. 
We will point out here some of the characteristics of the patients given the painful 
experience they have to go through. 
6.1 Patient´s previous history 
6.1.1 Alexithymia 
It refers to a specific disturbance in psychic functioning characterized by difficulties in the 
capacity to verbalize affections and to elaborate fantasies. OSCC leads the patient to a forced 
mutism sometimes preceded by poor verbal communication. Although initially described in 
the context of psychosomatic illnesses, alexithymic characteristics may be observed in 
patients with a wide range of medical and psychiatric disorders (Sifneos, Nemiah, 1973, 
cited by Marty, 1995).  
6.1.2 Traumatic episodes 
The existence of events that greatly disturbed the patients’ emotional lives may be 
interpreted as cumulative trauma. The clinical records of such patients reveal episodes of 
labour dissatisfaction, overadjustment  to extreme labour conditions, submission, 
unquestioned acceptance of social position, tragic loss of close relatives, change of roles or 
loss of working status.  
6.1.3 Vulnerability 
OSCC patients are vulnerable since the lesion is associated with unhealthy habits like 
alcoholism and tobacco addiction. Such habits are sometimes disruptive behaviours that 
appear as a consequence of unresolved affective problems. Bodily vulnerability (Zukerfeld, 
R. 1999, 2005) is defined as the possibility of either dysfunctional somatic behaviours and 
reactions to adverse, stressing factors or to cumulative trauma.   
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6.2 Emotional state during treatment 
Treatment shocks the OC patients in a global way, affecting their quality of life. They have 
to process a great deal of endogenous and exogenous stimuli. When the treatment is 
indicated, the first struggle is required: the patients have to adapt to a new routine, thus 
altering their usual habits; they have to accept new schedules and new premises even when 
they are far removed from their usual places of residence. The newly established routine 
increases the patients´ dependence since they need the care and attention of other persons as 
well as having to take care of themselves. Side effects produced by irradiation in the oral 
cavity make tasting, chewing and swallowing difficult. These impairments lead to loss of 
appetite and loss of weight, all of which tend to unbalance their emotional state.  Gaining 
weight becomes a major worry for the patients and their families. In some cases, the 
restrained, underlying anguish that has dominated the patient´s life finds a way out in the 
disease itself. That chronic state of dejection has been described in systemic patients as 
hidden depression, devoid of complaints or whining (Marty, 1966). 
6.3 Interdisciplinary approach 
In 2010, a partly structured, written survey was carried out. It was addressed to individual 
patients and to those acting as their companions who attended the Oncology Service at 
Hospital Nacional de Clínicas with the aim of finding out their opinion about the 
interdisciplinary care they were receiving. They were questioned about: Overall service 
performance (favourable or unfavourable), presence of several health professionals during 
consultation, patient´s suggestions to improve the service, optional therapies they would 
like to receive. The interviewed patients had been in contact with the service for a minimum 
of 3 months and a maximum of 6 years. Results: 53% of interviewed were male; 59% were 
smokers, 41% drank alcohol, 42% consumed both alcohol and tobacco. The 88% were 
satisfied, using the option “favourable” to describe their opinion about the service. They 
regarded the presence of dentists and psychologists in the team as very valuable; 71% 
declared they ignored the profession of the people present at consultation and 59 % stated 
they preferred to be seen by several professionals.   Concerning the medical services they 
would like to be offered, their preference rates were: social work (25%), physiotheraphy and 
language theraphy (18% each one) and personalized psychotherapy 12%. The following 
conclusions were drawn from the aforementioned results: the interdisciplinary team 
appears as a recommended approach for OC patients, not only because it focuses the 
disease comprehensively but also because the patients themselves expressed a positive point 
of view in its regard. Although the interdisciplinary approach to cancer patients is 
established in health systems, it is important to know how good this model works from the 
patient´s viewpoint. 
- The dynamics of consultation is mainly based on a unilateral information medical 
request, being the patient´s role fairly secondary. Most patients did not know the 
specialty of the professionals present at consultation.  
The patient plays a leading role both in defining and privileging his health problems and in 
accepting or refusing the possible solutions. Helping the patient to become active and to 
regain control of his own life is a desirable aim in every medical case. However, when 
dealing with OC patients, this goal acquires a special dimension. 
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6.4 The role of the psychologist 
Psycho oncology conceives cancer as a symptom of an illness comprising myriads of factors 
both at its starting point, during its course and in its recovery stage (Middleton, 2002). As a 
field of knowledge, psycho oncology goes beyond the limits of disciplinary knowledge. The 
role of the psychologist in the OC team may be summarized as follows: 
- Pave the way for a more interactive consultation by stimulating the patient´s participation 
in such a way that communication can flow more easily among patient, relatives and 
medical team.  
- Ask for and provide information. 
- Bring into consultation aspects related with the patient´s lifestyle : food, sleeping habits, 
leisure time, side effects of the treatment.  
- Lower the patient´s depersonalization caused by their illness and its demanding attention. 
- Propose the patient to make a critical reflection about the association between his 
lifestyle and his illness. 
- Assign due importance to the role of their companions and to their supporting net of 
relations. Encourage, support, challenge the patient and their family.  
- Contribute to install the idea that the illness should be perceived as a meaningful 
experience, as a chance for reflection and change.  
- Understand the incidence of psycho social factors during the course of the illness. 
As a member of the medical team dealing with OC patients, the psycho oncologist acts as a 
catalyst. His presence helps the patients´ psychological state, which may contribute to a 
better understanding of their reality. 
7. Conclusion  
OSCC has a bad prognosis and survival time is short in spite of the technological advances 
applied to treatments.  
Most patients, disregarding the initial symptoms, go to consultation at advanced OSCC 
stages. Pre-malignant lesions may appear 10 years before the initial OSCC manifestations. 
Although the carcinoma may be preventable through treatment of pre-cancerous lesions, 
many dentists and family physicians are not performing the opportunistic oral cavity  
exams. Oral cavity cancers can be detected easily with a simple oral examination, but 
compared to cancers that involve more elaborate screening tests (i.e., breast, prostate and 
colon), the rate of early diagnosis has not improved over time.  
OSCC is related to preventable risk factors. Therefore, we strongly advocate that doctors should 
discourage all their patients from smoking and drinking excessively. Furthermore, intensive 
public promotion and educational campaigns are imperative to increase patient awareness.  
Dental professionals have an important role both in  primary prevention of oral cancer -by 
inducing healthy life styles- and in secondary prevention by detecting oral cancer or its 
precursor lesions at early stages.  
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